Louise Gerbens obtained her medical degree at the University of Amsterdam and via the U.S. Educational Commission for Foreign Medical Graduates (ECFMG) certification. She is currently a resident in Dermatology at the Amsterdam University Medical Centers, expecting to complete her training in June 2021. She holds a PhD in Dermatology from the University of Amsterdam (2018), for which she investigated measurement instruments, datasets and systemic therapies for atopic eczema (pure.uva.nl/ws/files/22834815/Thesis.pdf). During her PhD, she became member of the Harmonising Outcome Measures for Eczema (HOME) initiative, for which she co-led the symptoms domain, and continues to serve as a board member. She also co-initiated the international (and Dutch) TREatment of ATopic eczema (TREAT) Registry Taskforce (treat-registry-taskforce.org, treatregister.nl), which is currently collecting data and has collaborators from 10 different countries.